Organ-on-Chip Technology

The future of drug discovery

TissueChips.com is the premium plural domain for the microphysiological systems market โ€” human organs on microfluidic chips replacing animal testing and accelerating personalized medicine.

$2.4B
Market by 2030
38%
Annual Growth Rate
90%
Drug Failure Reduction
.COM
Plural Authority

Human biology on a chip.

Tissue chips recreate organ-level physiology in microfluidic devices, enabling drug testing on human tissue instead of animal models.

๐Ÿซ€

Multi-Organ Systems

Heart, liver, lung, kidney, brain โ€” connected tissue chips model whole-body drug responses and toxicity.

๐Ÿงฌ

Patient-Specific

Chips built from patient cells enable personalized medicine and precision drug selection.

โšก

Faster Trials

Reduce preclinical testing from years to weeks. Identify failures before human trials.

๐Ÿ”ฌ

Better Predictions

Human tissue chips predict human outcomes. Animal models fail 90% of the time โ€” chips don't.

Own the plural.

TissueChips.com is the authoritative plural domain for organ-on-chip technology platforms, research consortiums, and industry publications.

Perfect for MPS platform companies, pharma R&D divisions, biotech startups, or academic research networks.